원격 임상시험 모니터링 도구 시장(2026-2030년)

The global remote clinical trial monitoring tools market is forecasted to grow by USD 5185.6 mn during 2025-2030, accelerating at a CAGR of 23.5% during the forecast period. The report on the global remote clinical trial monitoring tools market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rise of decentralized and hybrid clinical trial models, evolving frameworks and emphasis on risk-based monitoring, technological integration of AI and cloud computing.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global remote clinical trial monitoring tools market is segmented as below:

By Component

• Software
• Hardware
• Services

By End-User

• Pharmaceutical and biotech companies
• Contract research organizations
• Healthcare IT and service providers
• Academic and research institutes

By Deployment

• Cloud based
• On premises

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • The Netherlands
  • Spain
  • Russia
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the integration of predictive analytics and ml in monitoring as one of the prime reasons driving the global remote clinical trial monitoring tools market growth during the next few years. Also, proliferation of wearable technology and continuous patient monitoring and standardization of remote source data verification and interoperability will lead to sizable demand in the market.

The report on the global remote clinical trial monitoring tools market covers the following areas:

• Global remote clinical trial monitoring tools market sizing
• Global remote clinical trial monitoring tools market forecast
• Global remote clinical trial monitoring tools market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global remote clinical trial monitoring tools market vendors that include Advarra Inc., Anju Software Inc., Castor Research Inc., Cloudbyz Inc., Ennov SAS, Florence Healthcare., IQVIA Holdings Inc., Medable Inc., Medidata, Medrio Inc., Merative L.P., Microsoft Corp., Obvio Health USA Inc., OpenClinica LLC, Oracle Corp., Salesforce Inc., SAP SE, Signant Health, Veeva Systems Inc., Zoom Video Communications Inc.. Also, the global remote clinical trial monitoring tools market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Component
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Deployment
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Remote Clinical Trial Monitoring Tools Market 2020 - 2024
  • Historic Market Size - Data Table on Global Remote Clinical Trial Monitoring Tools Market 2020 - 2024 ($ million)
• 5.2 Component segment analysis 2020 - 2024
  • Historic Market Size - Component Segment 2020 - 2024 ($ million)
• 5.3 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.4 Deployment segment analysis 2020 - 2024
  • Historic Market Size - Deployment Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Remote Clinical Trial Monitoring Tools Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Component

• 8.1 Market segments
• 8.2 Comparison by Component
• 8.3 Software - Market size and forecast 2025-2030
• 8.4 Hardware - Market size and forecast 2025-2030
• 8.5 Services - Market size and forecast 2025-2030
• 8.6 Market opportunity by Component
  • Market opportunity by Component ($ million)

9 Market Segmentation by End-user

• 9.1 Market segments
• 9.2 Comparison by End-user
• 9.3 Pharmaceutical and biotech companies - Market size and forecast 2025-2030
• 9.4 Contract research organizations - Market size and forecast 2025-2030
• 9.5 Healthcare IT and service providers - Market size and forecast 2025-2030
• 9.6 Academic and research institutes - Market size and forecast 2025-2030
• 9.7 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

10 Market Segmentation by Deployment

• 10.1 Market segments
• 10.2 Comparison by Deployment
• 10.3 Cloud based - Market size and forecast 2025-2030
• 10.4 On premises - Market size and forecast 2025-2030
• 10.5 Market opportunity by Deployment
  • Market opportunity by Deployment ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 The Netherlands - Market size and forecast 2025-2030
  • 12.4.6 Spain - Market size and forecast 2025-2030
  • 12.4.7 Russia - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 India - Market size and forecast 2025-2030
  • 12.5.3 Japan - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
  • 12.5.7 Singapore - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Australia - Market size and forecast 2025-2030
  • 12.6.2 UAE - Market size and forecast 2025-2030
  • 12.6.3 Brazil - Market size and forecast 2025-2030
  • 12.6.4 South Africa - Market size and forecast 2025-2030
  • 12.6.5 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.6 Turkey - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rise of decentralized and hybrid clinical trial models
  • Evolving frameworks and emphasis on risk-based monitoring
  • Technological integration of AI and cloud computing
• 13.2 Market challenges
  • Data security and cybersecurity vulnerabilities
  • Interoperability and system integration complexity
  • Regulatory heterogeneity and site-level implementation barriers
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Integration of predictive analytics and ML in monitoring
  • Proliferation of wearable technology and continuous patient monitoring
  • Standardization of remote source data verification and interoperability

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Advarra Inc.
  • Advarra Inc. - Overview
  • Advarra Inc. - Product / Service
  • Advarra Inc. - Key offerings
  • SWOT
• 15.5 Anju Software Inc.
  • Anju Software Inc. - Overview
  • Anju Software Inc. - Product / Service
  • Anju Software Inc. - Key offerings
  • SWOT
• 15.6 Castor Research Inc.
  • Castor Research Inc. - Overview
  • Castor Research Inc. - Product / Service
  • Castor Research Inc. - Key offerings
  • SWOT
• 15.7 Cloudbyz Inc.
  • Cloudbyz Inc. - Overview
  • Cloudbyz Inc. - Product / Service
  • Cloudbyz Inc. - Key offerings
  • SWOT
• 15.8 Ennov SAS
  • Ennov SAS - Overview
  • Ennov SAS - Product / Service
  • Ennov SAS - Key offerings
  • SWOT
• 15.9 Florence Healthcare.
  • Florence Healthcare. - Overview
  • Florence Healthcare. - Product / Service
  • Florence Healthcare. - Key offerings
  • SWOT
• 15.10 IQVIA Holdings Inc.
  • IQVIA Holdings Inc. - Overview
  • IQVIA Holdings Inc. - Business segments
  • IQVIA Holdings Inc. - Key offerings
  • IQVIA Holdings Inc. - Segment focus
  • SWOT
• 15.11 Medable Inc.
  • Medable Inc. - Overview
  • Medable Inc. - Product / Service
  • Medable Inc. - Key offerings
  • SWOT
• 15.12 Medidata
  • Medidata - Overview
  • Medidata - Product / Service
  • Medidata - Key offerings
  • SWOT
• 15.13 Medrio Inc.
  • Medrio Inc. - Overview
  • Medrio Inc. - Product / Service
  • Medrio Inc. - Key offerings
  • SWOT
• 15.14 Merative L.P.
  • Merative L.P. - Overview
  • Merative L.P. - Product / Service
  • Merative L.P. - Key offerings
  • SWOT
• 15.15 Microsoft Corp.
  • Microsoft Corp. - Overview
  • Microsoft Corp. - Business segments
  • Microsoft Corp. - Key news
  • Microsoft Corp. - Key offerings
  • Microsoft Corp. - Segment focus
  • SWOT
• 15.16 Obvio Health USA Inc.
  • Obvio Health USA Inc. - Overview
  • Obvio Health USA Inc. - Product / Service
  • Obvio Health USA Inc. - Key offerings
  • SWOT
• 15.17 OpenClinica LLC
  • OpenClinica LLC - Overview
  • OpenClinica LLC - Product / Service
  • OpenClinica LLC - Key offerings
  • SWOT
• 15.18 Oracle Corp.
  • Oracle Corp. - Overview
  • Oracle Corp. - Business segments
  • Oracle Corp. - Key news
  • Oracle Corp. - Key offerings
  • Oracle Corp. - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations